Loading...
Passage Bio, Inc.
PASG•NASDAQ
Healthcare
Biotechnology
$6.15
$-0.19(-3.00%)
Passage Bio, Inc. (PASG) Financial Performance & Income Statement Overview
Review Passage Bio, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
35.05%
↑ 35.05%
Net Income Growth
36.54%
↑ 36.54%
Operating Cash Flow Growth
38.73%
↑ 38.73%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-93.59%
↓ 93.59%
ROIC
-100.92%
↓ 100.92%
Passage Bio, Inc. (PASG) Income Statement & Financial Overview
Review Passage Bio, Inc.'s (PASG) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $800000.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | -$800000.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $7.74M | $9.56M | $8.66M | $10.43M |
| SG&A Expenses | $6.08M | $4.71M | $7.25M | $6.51M |
| Operating Expenses | $13.82M | $14.27M | $20.70M | $17.38M |
| Total Costs & Expenses | $0.00 | $16.68M | $20.70M | $17.38M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $719000.00 | $759000.00 | $797000.00 |
| EBITDA | -$16.46M | -$13.55M | -$15.15M | -$16.14M |
| EBITDA Ratio | ||||
| Operating Income | -$16.46M | -$14.27M | -$20.70M | -$17.38M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $1.05M | $1.54M | $1.36M | $1.39M |
| Income Before Tax | -$15.40M | -$12.72M | -$19.34M | -$15.99M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$15.40M | -$12.72M | -$19.34M | -$15.99M |
| Net Income Ratio | ||||
| EPS | -$0.25 | -$0.21 | -$0.31 | -$0.26 |
| Diluted EPS | -$0.25 | -$0.21 | -$0.31 | -$0.26 |
| Weighted Avg Shares Outstanding | $62.11M | $62.06M | $61.76M | $61.68M |
| Weighted Avg Shares Outstanding (Diluted) | $62.11M | $62.06M | $61.76M | $61.68M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan